Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Annals of Surgical Oncology|April 29, 2014
Dualistic classification of epithelial ovarian cancer: surgical and survival outcomes in a large retrospective seriesPierluigi Benedetti Panici, Claudia Marchetti, Laura Salerno, et al.
International Journal of Surgery Case Reports|February 15, 2020
Post-conization cervical stenosis treated with silicone catheter in microinvasive cervical cancer patient: A case reportAngela Musella, Giusi Santangelo, Laura Vertechy, et al.
International Journal of Clinical Oncology|June 30, 2025
Platinum-rechallenge in epithelial ovarian cancer relapsing within 6 months after first-line treatment: a propensity score matching analysisLaura Vertechy, Raffaella Ergasti, Cristina Chiamenti, et al.
Oncology|September 26, 2017
Short-Infusion Trabectedin in Heavily Pretreated Ovarian Cancer Patients: A Single-Institution ExperienceClaudia Marchetti, Angela Musella, Alessia Romito, et al.
Oncotargets and Therapy|July 18, 2014
Targeted drug delivery via folate receptors in recurrent ovarian cancer: a reviewClaudia Marchetti, Innocenza Palaia, Margherita Giorgini, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 8, 2026
Olaparib dose reduction in BRCA-mutated platinum-sensitive ovarian cancer recurrence: real-world dataSerena Maria Boccia, Matteo Bruno, Camilla Culcasi, et al.
Journal of Medical Case Reports|June 20, 2014
Nonabsorbable suture granuloma mimicking ovarian cancer recurrence at combined positron emission tomography/computed tomography evaluation: a case reportLudovica Imperiale, Claudia Marchetti, Laura Salerno, et al.
International Journal of Clinical Oncology|November 4, 2025
Real-life observational study on niraparib in older patients with primary tubo-ovarian cancer: a focus on safety and efficacyAdriana Ionelia Apostol, Matteo Bruno, Carolina Maria Sassu, et al.
Cancer Treatment Reviews|April 2, 2018
Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancerAngela Musella, Erlisa Bardhi, Claudia Marchetti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2026
The impact of BRCA status on the efficacy of paclitaxel monotherapy in recurrent ovarian cancerGiorgia Russo, Adriana Ionelia Apostol, Ilary Ruscito, et al.
Pageof 3